TAZ promotes PC2 degradation through a SCFβ-Trcp E3 ligase complex

Molecular and Cellular Biology

Volumn 27, Issue 18, 2007, Pages 6383-6395

  Tian, Yu ^a   Kolb, Robert ^b   Hong, Jeong Ho ^c,d   Carroll, John ^a   Li, Dawei ^a   You, John ^a   Bronson, Roderick ^a   Yaffe, Michael B ^c   Zhou, Jing ^b   Benjamin, Thomas ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

F BOX PROTEIN; POLYCYSTIN 1; POLYCYSTIN 2; PROTEIN TAZ; SERINE; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMPHYSEMA; IMMUNOPRECIPITATION; KIDNEY POLYCYSTIC DISEASE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; UBIQUITINATION; WESTERN BLOTTING; ZEBRA FISH;

ANIMALS; CELL LINE; CULLIN PROTEINS; F-BOX PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PRECIPITIN TESTS; PROTEINS; RECOMBINANT PROTEINS; SKP CULLIN F-BOX PROTEIN LIGASES; TRANSCRIPTION FACTORS; TRPP CATION CHANNELS; UBIQUITINS;

DANIO RERIO; MUS; VERTEBRATA;

EID: 34548719323     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00254-07     Document Type: Article

References (68)

1. Ahn, M. Y., S. C. Bae, M. Maruyama, and Y. Ito. 1996. Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFα gene family. Gene 168:279-280.
2. Amsterdam, A., S. Burgess, G. Golling, W. Chen, Z. Sun, K. Townsend, S. Farrington, M. Haldi, and N. Hopkins. 1999. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 13:2713-2724.
3. Bai, C., P. Sen, K. Hofmann, L. Ma, M. Goebl, J. W. Harper, and S. J. Elledge. 1996. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86:263-274.
4. waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109:157-168.
5. Busino, L., M. Donzelli, M. Chiesa, D. Guardavaccaro, D. Ganoth, N. V. Dorrello, A. Hershko, M. Pagano, and G. F. Draetta. 2003. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426:87-91.
6. Cai, Y., G. Anyatonwu, D. Okuhara, K. B. Lee, Z. Yu, T. Onoe, C. L. Mei, Q. Qian, L. Geng, R. Wiztgall, B. E. Ehrlich, and S. Somlo. 2004. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J. Biol. Chem. 279:19987-19995.
7. Calvet, J. P. 2002. Cilia in PKD - letting it all hang out. J. Am. Soc. Nephrol. 13:2614-2616.
8. Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199.
9. Cui, C. B., L. F. Cooper, X. Yang, G. Karsenty, and I. Aukhil. 2003. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol. Cell. Biol. 23:1004-1013.
10. Delmas, P., S. M. Nauli, X. Li, B. Coste, N. Osorio, M. Crest, D. A. Brown, and J. Zhou. 2004. Gating of the polycystin ion channel signaling complex in neurons and kidney cells. FASEB J. 18:740-742.
11. Delmas, P., H. Nomura, X. Li, M. Lakkis, Y. Luo, Y. Segal, J. M. Fernandez-Fernandez, P. Harris, A. M. Frischauf, D. A. Brown, and J. Zhou. 2002. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J. Biol. Chem. 277:11276-11283.
12. Dick, L. R., A. A. Cruikshank, L. Grenier, F. D. Melandri, S. L. Nunes, and R. L. Stein. 1996. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin β-lactone. J. Biol. Chem. 271:7273-7276.
13. Drummond, I. A., A. Majumdar, H. Hentschel, M. Elger, L. Solnica-Krezel, A. F. Schier, S. C. Neuhauss, D. L. Stemple, F. Zwartkruis, Z. Rangini, W. Driever, and M. C. Fishman. 1998. Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development 125:4655-4667.
14. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731.
15. Flaherty, L., E. C. Bryda, D. Collins, U. Rudofsky, and J. C. Montogomery. 1995. New mouse model for polycystic kidney disease with both recessive and dominant gene effects. Kidney Int. 47:552-558.
16. Fry, J. L., Jr., W. E. Koch, J. C. Jennette, E. McFarland, F. A. Fried, and J. Mandell. 1985. A genetically determined murine model of infantile polycystic kidney disease. J. Urol. 134:828-833.
17. 2+-permeable nonselective cation channel. Proc. Natl. Acad. Sci. USA 98:1182-1187.
18. Guay-Woodford, L. M. 2003. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am. J. Physiol. Renal Physiol. 285:F1034-F1049.
19. Guay-Woodford, L. M., E. C. Bryda, B. Christine, J. R. Lindsey, W. R. Collier, E. D. Avner, P. D'Eustachio, and L. Flaherty. 1996. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic. Kidney Int. 50:1158-1165.
20. Hanaoka, K., F. Qian, A. Boletta, A. K. Bhunia, K. Piontek, L. Tsiokas, V. P. Sukhatme, W. B. Guggino, and G. G. Germino. 2000. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408:990-994.
21. Hong, J. H., E. S. Hwang, M. T. McManus, A. Amsterdam, Y. Tian, R. Kalmukova, E. Mueller, T. Benjamin, B. M. Spiegelman, P. A. Sharp, N. Hopkins, and M. B. Yaffe. 2005. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074-1078.
22. Hossain, Z., S. M. Ali, H. L. Ko, J. Xu, C. P. Ng, K. Guo, Z. Qi, S. Ponniah, W. Hong, and W. Hunziker. 2007. Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc. Natl. Acad. Sci. USA 104:1631-1636.
23. Hughes, J., C. J. Ward, B. Peral, R. Aspinwall, K. Clark, J. L. San Millan, V. Gamble, and P. C. Harris. 1995. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10:151-160.
24. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129-4135.
25. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13:4918-4927.
26. International Polycystic Kidney Disease Consortium. 1995. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81:289-298.
27. Ito, Y. 1989. Signals and transcription factors. Gan To Kagaku Ryoho 16:509-515. (In Japanese.)
28. Jin, J., T. Shirogane, L. Xu, G. Nalepa, J. Qin, S. J. Elledge, and J. W. Harper. 2003. SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17:3062-3074.
29. Kanai, F., P. A. Marignani, D. Sarbassova, R. Yagi, R. A. Hall, M. Donowitz, A. Hisaminato, T. Fujiwara, Y. Ito, L. C. Cantley, and M. B. Yaffe. 2000. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19:6778-6791.
30. Kimberling, W. J., P. R. Fain, J. B. Kenyon, D. Goldgar, E. Sujansky, and P. A. Gabow. 1988. Linkage heterogeneity of autosomal dominant polycystic kidney disease. N. Engl. J. Med. 319:913-918.
31. Koulen, P., Y. Cai, L. Geng, Y. Maeda, S. Nishimura, R. Witzgall, B. E. Ehrlich, and S. Somlo. 2002. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4:191-197.
32. 2+ release from intracellular stores in Caenorhabditis elegans. Cell Calcium 37:593-601.
33. Lantinga-van Leeuwen, I. S., J. G. Dauwerse, H. J. Baelde, W. N. Leonhard, A. van de Wal, C. J. Ward, S. Verbeek, M. C. Deruiter, M. H. Breuning, E. de Heer, and D. J. Peters. 2004. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13:3069-3077.
34. Li, Q. L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X. Z. Chi, K. Y. Lee, S. Nomura, C. W. Lee, S. B. Han, H. M. Kim, W. J. Kim, H. Yamamoto, N. Yamashita, T. Yano, T. Ikeda, S. Itohara, J. Inazawa, T. Abe, A. Hagiwara, H. Yamagishi, A. Ooe, A. Kaneda, T. Sugimura, T. Ushijima, S. C. Bae, and Y. Ito. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124.
35. Lund, A. H., and M. van Lohuizen. 2002. RUNX: a trilogy of cancer genes. Cancer Cell 1:213-215.
36. 2+-permeable cation channel in renal epithelia. Mol. Cell. Biol. 23:2600-2607.
37. Mahoney, W. M., Jr., J. H. Hong, M. B. Yaffe, and I. K. Farrance. 2005. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem. J. 388:217-225.
38. Mochizuki, T., G. Wu, T. Hayashi, S. L. Xenophontos, B. Veldhuisen, J. J. Saris, D. M. Reynolds, Y. Cai, P. A. Gabow, A. Pierides, W. J. Kimberling, M. H. Breuning, C. C. Deltas, D. J. Peters, and S. Somlo. 1996. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342.
39. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066.
40. Murakami, M., M. Nakagawa, E. N. Olson, and O. Nakagawa. 2005. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc. Natl. Acad. Sci. USA 102:18034-18039.
41. Murakami, M., J. Tominaga, R. Makita, Y. Uchijima, Y. Kurihara, O. Nakagawa, T. Asano, and H. Kurihara. 2006. Transcriptional activity of Pax3 is co-activated by TAZ. Biochem. Biophys. Res. Commun. 339:533-539.
42. Nauli, S. M., F. J. Alenghat, Y. Luo, E. Williams, P. Vassilev, X. Li, A. E. Elia, W. Lu, E. M. Brown, S. J. Quinn, D. E. Ingber, and J. Zhou. 2003. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33:129-137.
43. Nauli, S. M., and J. Zhou. 2004. Polycystins and mechanosensation in renal and nodal cilia. Bioessays 26:844-856.
44. Nawaz, Z., D. M. Lonard, C. L. Smith, E. Lev-Lehman, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1999. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19:1182-1189.
45. Park, K. S., J. A. Whitsett, T. Di Palma, J. H. Hong, M. B. Yaffe, and M. Zannini. 2004. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J. Biol. Chem. 279:17384-17390.
46. Parnell, S. C., B. S. Magenheimer, R. L. Maser, C. A. Zien, A. M. Frischauf, and J. P. Calvet. 2002. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J. Biol. Chem. 277:19566-19572.
47. Pazour, G. J., B. L. Dickert, Y. Vucica, E. S. Seeley, J. L. Rosenbaum, G. B. Witman, and D. G. Cole. 2000. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J. Cell Biol. 151:709-718.
48. Pei, Y., T. Watnick, N. He, K. Wang, Y. Liang, P. Parfrey, G. Germino, and P. St. George-Hyslop. 1999. Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 10:1524-1529.
49. Peters, D. J., and L. A. Sandkuijl. 1992. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib. Nephrol. 97:128-139.
50. Preminger, G. M., W. E. Koch, F. A. Fried, E. McFarland, E. D. Murphy, and J. Mandell. 1982. Murine congenital polycystic kidney disease: a model for studying development of cystic disease. J. Urol. 127:556-560.
51. Pritchard, L., J. A. Sloane-Stanley, J. A. Sharpe, R. Aspinwall, W. Lu, V. Buckle, L. Strmecki, D. Walker, C. J. Ward, C. E. Alpers, J. Zhou, W. G. Wood, and P. C. Harris. 2000. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype, Hum. Mol. Genet. 9:2617-2627.
52. Qian, F., F. J. Germino, Y. Cai, X. Zhang, S. Somlo, and G. G. Germino. 1997. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 16:179-183.
53. Qian, F., T. J. Watnick, L. F. Onuchic, and G. G. Germino. 1996. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87:979-987.
54. Reeders, S. T. 1992. Multilocus polycystic disease. Nat. Genet. 1:235-237.
55. Satake, M., T. Ibaraki, Y. Yamaguchi, and Y. Ito. 1989. Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene. J. Virol. 63:3669-3677.
56. Shao, X., J. E. Johnson, J. A. Richardson, T. Hiesberger, and P. Igarashi. 2002. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J. Am. Soc. Nephrol. 13:1824-1836.
57. Sun, Z., A. Amsterdam, G. J. Pazour, D. G. Cole, M. S. Miller, and N. Hopkins. 2004. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131:4085-4093.
58. Takahashi, H., J. P. Calvet, D. Dittemore-Hoover, K. Yoshida, J. J. Grantham, and V. H. Gattone II. 1991. A hereditary model of slowly progressive polycystic kidney disease in the mouse. J. Am. Soc. Nephrol 1:980-989.
59. Tian, Y., D. Li, J. Dahl, J. You, and T. Benjamin. 2004. Identification of TAZ as a binding partner of the polyomavirus T antigens. J. Virol. 78:12657-12664.
60. Tsiokas, L., E. Kim, T. Arnould, V. P. Sukhatme, and G. Walz. 1997. Homo-and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl. Acad. Sci. USA 94:6965-6970.
61. Skp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661-664.
62. 2+ homeostasis in polycystic kidney disease. Biochem. Biophys. Res. Commun. 282:341-350.
63. Winocour, E. 1963. Purification of polyomavirus. Virology 19:158-168.
64. Winston, J. T., P. Strack, P. Beer-Romero, C. Y. Chu, S. J. Elledge, and J. W. Harper. 1999. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13:270-283.
65. Wu, G., V. D'Agati, Y. Cai, G. Markowitz, J. H. Park, D. M. Reynolds, Y. Maeda, T. C. Le, H. Hou, Jr., R. Kucherlapati, W. Edelmann, and S. Somlo. 1998. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93:177-188.
66. Wu, G., and S. Somlo. 2000. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. Mol. Genet. Metab. 69:1-15.
67. Yoder, B. K., X. Hou, and L. M. Guay-Woodford. 2002. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 13:2508-2516.
68. Zolotnitskaya, A., and L. M. Satlin. 1999. Developmental expression of ROMK in rat kidney. Am. J. Physiol. 276:F825-F836.